GH
CERE

GAM Holding’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

GAM Holding’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,000
Closed -$204K – 174
2024
Q2 		$204K Sell
5,000
-1,000
-17% -$41.6K 0.02% 157
2024
Q1 		$254K Buy
6,000
+1,000
+20% +$42K 0.02% 162
2023
Q4 		$212K Buy
+5,000
New +$144K 0.02% 160

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

GAM Holding's CERE Position: Q3 2024 in Review

GAM Holding sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 5,000 shares — an estimated $204K sold.

GAM Holding first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $254K in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • GAM Holding reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • GAM Holding sold 5,000 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $204K.
  • GAM Holding first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • GAM Holding's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $254K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on GAM Holding's 13F filing for Q3 2024, filed 22 Oct 2024.